http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-6160329-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4706 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 2008-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5439acd4b854b8b398c5e35712a89f03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff6196fc751ebcd10cbe40695f88647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93ad8e75995919bb948af9434b12dd9a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a8809570e2352a3cab8cacc1e6312b2 |
publicationDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CO-6160329-A2 |
titleOfInvention | VR1 BENCIMIDAZOLIC MODULATORS |
abstract | and a form thereof where: the dashed lines between positions 1, 2 and 3 of Formula (I) indicate the positions of a double tautomeric bond, where when a double bond is formed between positions 1 and 2, then R3b is present and where, when a double bond is formed between positions 2 and 3, then R3a is present; p is 1 or 2; q is 0 or 1; r is 0, 1, 2 or 3; L is C1-3 alkyl, C2-3 alkenyl, C2-3 alkynyl or cyclopropyl; A1 is selected from the group consisting of phenyl, biphenyl, naphthyl, pyridinyl, quinolinyl and indole; each R1 is selected from the group consisting of hydroxy, cyano, halogen, formyl, carboxy, alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 alkylcarbonyl, C1-6 alkoxycarbonyl, C1-6 alkylthio , C 1-6 alkylsulfonyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-4 alkyl, C 3-8 cycloalkyl-C 1-4 alkoxy, C 3-8 cycloalkyl-oxygen, amino, (C 1-6 alkyl) 1-2 amino, ( C3-8 cycloalkyl 1-2amino, (C3-8-C1-4alkyl) 1-2amino, aminocarbonyl, (C1-6 alkyl) 1-2 aminocarbonyl, C1-6 alkylcarbonylamino, C1-6 alkoxycarbonylamino, aminocarbonylamino, ( C1-6 alkyl) 1-2aminocarbonylamino, C1-6 alkylsulfonylamino, C1-6 alkylsulfinylamino, aminosulfonyl, (C1-4 alkyl) 1-2aminosulfonyl, aminosulfonylamino and (C1-6 alkyl) 1-2 aminosulfonylamino, where the alkyl is optionally substituted with C1-8 alkoxy, amino, (C1-4 alkyl) 1-2amino, C1-6 alkylcarbonylamino, C1-6 alkoxycarbonylamino, aminocarbonylamino, (C1-6 alkyl) 1-2aminocarbonylamino, C1-6 alkylsulfonylamino, alkylsulfinylamino C1-6, aminosulfonyl, (C1-4 alkyl) 1-2 aminosulfonyl, aminosulfonylamino and (C1-6 alkyl) 1-2 aminosulfonylamino, where the alkyl is optionally substituted with C1-8 alkoxy, amino, (C1-4 alkyl) 1-2 amino, C1-6 alkylcarbonylamino, C1-6 alkoxycarbonylamino, aminocarbonylamino, (C1-6 alkyl) 1-2 aminocarbonylamino, C1-6 alkylsulfonylamino, aminosulfonylamino, ... |
priorityDate | 2006-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.